Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
for Corneal Scar
Sites in Minnetonka +6 more locations
Sponsor: Claris Biotherapeutics, Inc.
Sex: All·Age: 18 - 80
Code: NCT06257355·Phase 1·Recruiting·Listed Feb 2024